Showing 2 of 2 recruiting trials for “Immune-mediated thrombotic thrombocytopenic purpura”
A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
RecruitingNCT04985318 ↗
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP
👨⚕️ Linus Völker, MD, Department II of Internal Medicine, University of Cologne📍 1 site📅 Started Mar 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →